Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.

NCT02770729 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

3640

Enrollment

OTHER

Sponsor class

Conditions

Endophthalmitis

Interventions

DRUG: Moxifloxacin
DRUG: No injection of moxifloxacin

Sponsor

University of Campinas, Brazil